Drugs Made In America Acquisition DMAAU
NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAU) Change in Accured Expenses (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Change in Accured Expenses came in at -$80439.0 in Q4 2025, down 151.84% on a QoQ basis from $155170.0 in Q3 2025.

Drugs Made In America Acquisition Corp. (DMAAU) Change in Accured Expenses (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of Change in Accured Expenses data on file, last reported at -$80439.0 in Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A year-over-year to -$80439.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144904.0 (changed N/A YoY) and the FY2025 annual result came in at $144904.0, up 87.51% from the prior year.
  • Change in Accured Expenses slipped to -$80439.0 in Q4 2025, from $155170.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $155170.0 in Q3 2025 to a low of -$80439.0 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 -80,439.00
Dec 31, 2025 -80,439.00
Sep 30, 2025 155,170.00
Sep 30, 2025 155,170.00
Jun 30, 2025 14,970.00
Jun 30, 2025 14,970.00
Mar 31, 2025 55,203.00
Mar 31, 2025 55,203.00